Mast cells from different molecular and prognostic subtypes of systemic mastocytosis display distinct immunophenotypes

被引：105

作者：

Teodosio, Cristina ^{[1
,2
]}

Garcia-Montero, Andres C. ^{[1
,2
]}

Jara-Acevedo, Maria ^{[1
,2
]}

Sanchez-Munoz, Laura ^{[3
]}

Alvarez-Twose, Ivan ^{[3
]}

Nunez, Rosa ^{[4
]}

Schwartz, Lawrence B. ^{[5
]}

Walls, Andrew F. ^{[6
]}

Escribano, Luis ^{[3
]}

Orfao, Alberto ^{[1
,2
]}

机构：

[1] IBMCC CSIC USAL, Ctr Invest Canc, Serv Gen Citometria, Inst Biol Mol & Celular Cancer, Salamanca 37007, Spain

[2] Univ Salamanca, Dept Med, E-37008 Salamanca, Spain

[3] Hosp Virgen Valle, KF Austen Lab, Ctr Estudios Mastocitosis Castilla Mancha, Toledo, OH USA

[4] Hosp Ramon & Cajal, Serv Hematol, E-28034 Madrid, Spain

[5] Virginia Commonwealth Univ, Div Rheumatol Allergy & Immunol, Dept Internal Med, Richmond, VA 23284 USA

[6] Southampton Gen Hosp, Immunopharmacol Grp, Southampton SO9 4XY, Hants, England

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2010年 / 125卷 / 03期

基金：

美国国家卫生研究院;

关键词：

Mastocytosis; immunophenotype; flow cytometry; KIT mutations; FLOW-CYTOMETRIC ANALYSIS; BONE-MARROW; KIT MUTATION; M-RAS; EXPRESSION; ACTIVATION; ANTIGENS; TRYPTASE; LEUKEMIA; DISEASE;

D O I：

10.1016/j.jaci.2009.10.020

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

Background: Systemic mastocytosis (SM) is a heterogeneous group of disorders with distinct clinical and biological behavior. Despite this, little is known about the immunophenotypic features of the distinct diagnostic categories of SM. Objective: To analyze the immunophenotypic characteristics of bone marrow (BM) mast cells (MCs) of different subtypes of SM. Methods: Bone marrow samples from 123 patients with different subtypes of SM and 92 controls were analyzed for a broad panel of immunophenotypic markers by flow cytometry. Results: Three clearly different maturation-associated immunophenotypic profiles were found for BMMCs in SM. These different profiles were associated with both genetic markers of the disease and its clinical behavior. BMMCs from poor-prognosis categories of SM (aggressive SM and MC leukemia) typically showed an immature phenotype with clonal involvement of all myeloid lineages by the D816V stem cell growth factor receptor gene (KIT) mutation. In turn, a mature activated versus resting BMMC immunophenotype was commonly found among patients with good-prognosis subtypes of SM depending on whether they carried (indolent SM and clonal MC activation disorders) or not (well differentiated SM) the D816V KIT mutation. Conclusion: Bone marrow MCs from SM show 3 different maturation-related immunophenotypic profiles that are associated with both the genetic markers of the disease and its clinical behavior. (J Allergy Clin Immunol 2010;125:719-26.)

引用

页码：719 / 726

页数：8

共 45 条

[1] A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib [J].

Akin, C ;

Fumo, G ;

Yavuz, AS ;

Lipsky, PE ;

Neckers, L ;

Metcalfe, DD .

BLOOD, 2004, 103 (08) :3222-3225

[2]

Akin C., 2004, Journal of Allergy and Clinical Immunology, V113, pS327, DOI 10.1016/j.jaci.2004.01.683

[3] Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with "idiopathic" anaphylaxis [J].

Akin, Cem ;

Scott, Linda M. ;

Kocabas, Can N. ;

Kushnir-Sukhov, Nataliya ;

Brittain, Erica ;

Noel, Pierre ;

Metcalfe, Dean D. .

BLOOD, 2007, 110 (07) :2331-2333

[4] Proapoptotic Bcl-2 family member Bim is involved in the control of mast cell survival and is induced together with Bcl-XL upon IgE-receptor activation [J].

Alfredsson, J ;

Puthalakath, H ;

Martin, H ;

Strasser, A ;

Nilsson, G .

CELL DEATH AND DIFFERENTIATION, 2005, 12 (02) :136-144

[5] Clonal mast cell disorders in patients with systemic reactions to Hymenoptera stings and increased serum tryptase levels [J].

Bonadonna, Patrizia ;

Perbellini, Omar ;

Passalacqua, Giovanni ;

Caruso, Beatrice ;

Colarossi, Sabrina ;

Dal Fior, Daniela ;

Castellani, Luca ;

Bonetto, Chiara ;

Frattini, Francesco ;

Dama, Annarita ;

Martinelli, Giovanni ;

Chilosi, Marco ;

Senna, Gianenrico ;

Pizzolo, Giovanni ;

Zanotti, Roberta .

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2009, 123 (03) :680-686

[6]

Cerveró C, 1999, AM J HEMATOL, V60, P191, DOI 10.1002/(SICI)1096-8652(199903)60:3<191::AID-AJH4>3.0.CO

[7]

2-Y

[8] Quantitative multiparametric immunophenotyping in acute lymphoblastic leukemia: correlation with specific genotype. I. ETV6/AML1 ALLs identification [J].

De Zen, L ;

Orfao, A ;

Cazzaniga, G ;

Masiero, L ;

Cocito, MG ;

Spinelli, M ;

Rivolta, A ;

Biondi, A ;

Zanesco, L ;

Basso, G .

LEUKEMIA, 2000, 14 (07) :1225-1231

[9] The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease [J].

Díaz-Agustin, B ;

Escribano, L ;

Bravo, P ;

Herrero, S ;

Nuñez, R ;

Navalón, R ;

Navarro, L ;

Torrelo, A ;

Cantalapiedra, A ;

del Castillo, L ;

Villarrubia, J ;

Navarro, JL ;

San Miguel, JF ;

Orfao, A .

BRITISH JOURNAL OF HAEMATOLOGY, 1999, 106 (02) :400-405

[10] Indolent systemic mast cell disease in adults:: Immunophenotypic characterization of bone marrow mast cells and its diagnostic implications [J].

Escribano, L ;

Orfao, A ;

Díaz-Agustin, B ;

Villarrubia, J ;

Cerveró, C ;

López, A ;

Marcos, MAG ;

Bellas, C ;

Fernández-Cañadas, S ;

Cuevas, M ;

Sánchez, A ;

Velasco, JL ;

Navarro, JL ;

San Miguel, JF .

BLOOD, 1998, 91 (08) :2731-2736

← 1 2 3 4 5 →